INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2017

Controlled-release melatonin and doxepin are recommended as first-line therapies for insomnia in older adults.

This review evaluates pharmacologic therapies for insomnia. Controlled-release melatonin and doxepin are recommended as first-line agents in older adults, while z-drugs should be reserved if those are ineffective. For the general population, controlled-release melatonin and z-drugs can be considered for difficulty falling asleep, and low-dose doxepin and z-drugs for difficulty staying asleep. Benzodiazepines, sedating antihistamines, antiepileptics, and atypical antipsychotics are generally not recommended.

Study type
Narrative review
Who was studied
Patients with insomnia, including older adults and the general population
What was measured
Efficacy and safety of pharmacologic therapies for insomnia

THE PAPER

Insomnia: Pharmacologic Therapy.

Matheson E, Hainer BL. Am Fam Physician, 2017.

PubMed 28671376 ↗

Brain & moodHealthy aging & longevityOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.